| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 32.079 | 81.995 | 91.502 | 104.968 | 134.884 | 129.941 | 180.320 | 238.681 | 156.923 | 160.050 |
| Total Income - EUR | 35.734 | 82.099 | 92.943 | 106.025 | 137.133 | 132.058 | 180.345 | 239.346 | 156.991 | 162.658 |
| Total Expenses - EUR | 30.674 | 76.302 | 87.600 | 102.311 | 129.116 | 129.600 | 159.604 | 234.480 | 171.016 | 180.479 |
| Gross Profit/Loss - EUR | 5.060 | 5.797 | 5.343 | 3.715 | 8.017 | 2.458 | 20.741 | 4.865 | -14.025 | -17.821 |
| Net Profit/Loss - EUR | 4.247 | 4.155 | 4.414 | 2.654 | 6.645 | 1.224 | 18.933 | 2.588 | -15.517 | -21.832 |
| Employees | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
Check the financial reports for the company - Giral Biocons Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 16.301 | 17.885 | 16.835 | 18.084 | 17.145 | 16.246 | 14.812 | 13.681 | 12.479 | 11.792 |
| Current Assets | 71.473 | 81.875 | 120.903 | 118.791 | 81.947 | 95.050 | 139.113 | 164.067 | 196.583 | 168.361 |
| Inventories | 55.683 | 65.624 | 90.765 | 99.968 | 73.710 | 88.957 | 127.397 | 142.366 | 168.519 | 131.957 |
| Receivables | 14.249 | 14.225 | 18.166 | 16.065 | 6.693 | 5.875 | 9.553 | 14.723 | 17.924 | 20.541 |
| Cash | 1.542 | 2.026 | 11.972 | 2.758 | 1.544 | 217 | 2.163 | 6.978 | 10.141 | 15.863 |
| Shareholders Funds | 4.207 | 10.450 | 14.687 | 17.071 | 23.386 | 24.208 | 42.605 | 45.325 | 29.670 | 1.573 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 83 | 81 | 81 | 81 | 80 |
| Debts | 83.568 | 89.311 | 123.051 | 119.803 | 75.706 | 87.088 | 111.320 | 132.424 | 179.391 | 178.580 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4683 - 4683" | |||||||||
| CAEN Financial Year |
4613
|
|||||||||
Comments - Giral Biocons Srl